Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Have you noticed any changes in cholesterol levels?What if liver tests abnormal during lipitor use?Is veklury used in hospitals?Does protein binding impact lipitor's protein target interaction?What's the change in heart rate with lyrica and exercise?
See the DrugPatentWatch profile for marqibo
Yes. Marqibo is a brand-name formulation of vincristine that is encapsulated in liposomes, meaning it is a liposomal form of vincristine. [1]
“Liposomal vincristine” refers to vincristine packaged in liposomes (tiny lipid-based carriers). This delivery system is used to change how the drug is distributed in the body compared with standard vincristine formulations. [1]
Using a liposomal delivery system is part of what differentiates Marqibo from other vincristine products, which can affect dosing schedules and safety considerations. For vincristine products, clinicians also pay close attention to dosing and administration because vincristine is not the same as “vincristine sulfate” given by mistake in other contexts. [1]
DrugPatentWatch.com lists Marqibo as liposomal vincristine. [1] Sources: [1] https://www.drugpatentwatch.com/ (Search “Marqibo liposomal vincristine” on the site)